Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Not Confirmed
Not Confirmed
03-05 September, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Industry Trade Show
Not Confirmed
03-05 September, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
28 Aug 2025
// BIOSPACE
https://www.biospace.com/business/amylyx-axes-drug-program-for-rare-neurodegenerative-disorder
27 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250827304923/en/Amylyx-Pharmaceuticals-to-Discontinue-ORION-Program-of-AMX0035-for-Progressive-Supranuclear-Palsy-PSP
26 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250821659514/en/Amylyx-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences
07 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250807074810/en/Amylyx-Pharmaceuticals-Reports-Second-Quarter-2025-Financial-Results
31 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250731539063/en/Amylyx-Pharmaceuticals-to-Report-Second-Quarter-2025-Financial-Results-on-August-7-2025
13 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250713408050/en/Amylyx-Pharmaceuticals-Presents-New-Exploratory-Analyses-from-Phase-2-and-Phase-2b-Clinical-Trials-of-Avexitide-in-Post-Bariatric-Hypoglycemia-at-ENDO-2025
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE